menu
    • menu

    Company profile for Personalis

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Personalis, Inc. is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Our patented ACE (Accuracy and Content Enhanced) Technology forms the foundation of all Personalis products. ACE Technology improves every individual step in the next-generation sequencing (NGS) process, from nucleic acid extraction, ...
    Personalis, Inc. is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. Our patented ACE (Accuracy and Content Enhanced) Technology forms the foundation of all Personalis products. ACE Technology improves every individual step in the next-generation sequencing (NGS) process, from nucleic acid extraction, to sequencing assays, to data analytics. This makes it possible for us to achieve augmented coverage of difficult-to-sequence genomic regions that are missed with the use of conventional sequencing techniques.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PersonalisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1330 O’Brien Drive Menlo Park, CA 94025
    Telephone
    Telephone
    +49 170 8121 888
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.personalis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Personalis to showcase ultrasensitive ctDNA data at AACR 2026
    Personalis to showcase ultrasensitive ctDNA data at AACR 2026

    13 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260413770148/en/Personalis-and-Collaborators-to-Highlight-Ultrasensitive-ctDNA-Data-and-New-Therapy-Resistance-Tracking-Capabilities-at-AACR-2026

    BUSINESSWIRE
    13 Apr 2026
    Share Share
    Personalis to Present at Needham 25th Annual Virtual Conference
    Personalis to Present at Needham 25th Annual Virtual Conference

    01 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260401441917/en/Personalis-to-Participate-in-the-25th-Annual-Needham-Virtual-Conference

    BUSINESSWIRE
    01 Apr 2026
    Share Share
    Personalis Appoints President To Accelerate MRD Adoption
    Personalis Appoints President To Accelerate MRD Adoption

    17 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-17/personalis-appoints-dr-richard-chen-as-president-to-further-accelerate-mrd-adoption

    PHARMIWEB
    17 Mar 2026
    Share Share
    Personalis To Present At TD Cowen 46th Healthcare Conference
    Personalis To Present At TD Cowen 46th Healthcare Conference

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217655785/en/Personalis-to-Participate-in-the-TD-Cowen-46th-Annual-Healthcare-Conference

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Personalis To Report Q4 And Full Year 2025 Financial Results
    Personalis To Report Q4 And Full Year 2025 Financial Results

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212390848/en/Personalis-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Personalis NeXT Personal Wins Medicare Coverage for Lung Cancer
    Personalis NeXT Personal Wins Medicare Coverage for Lung Cancer

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210400555/en/Personalis-Receives-Medicare-Coverage-for-NeXT-Personal-in-Lung-Cancer-Surveillance

    BUSINESSWIRE
    10 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search